Journal of Diabetes and Its Complications
Volume 24, Issue 4 , Pages 223-228 , July 2010

Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes

  • Jakob Grauslund

      Affiliations

    • Department of Ophthalmology, Odense University Hospital, Odense, Denmark
    • Corresponding Author InformationCorresponding author. Department of Ophthalmology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark. Tel.: +45 6541 3196; fax: +45 6612 6387.
    • ,
  • Trine M.M. Jørgensen

      Affiliations

    • Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark
    • ,
  • Mads Nybo

      Affiliations

    • Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark
    • ,
  • Anders Green

      Affiliations

    • Department of Applied Research and Health Technology Assessment, Odense University Hospital, Odense, Denmark
    • Epidemiology, Institute of Public Health, University of Southern Denmark, Odense, Denmark
    • ,
  • Lars M. Rasmussen

      Affiliations

    • Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark
    • ,
  • Anne Katrin Sjølie

      Affiliations

    • Department of Ophthalmology, Odense University Hospital, Odense, Denmark

Received 11 March 2009 ,Accepted 12 May 2009.

References 

  1. DERI group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine. 1993;329:977–986
  2. Dorman JS, LaPorte RE, Kuller LH, Cruickshanks KJ, Orchard TJ, Wagener DK, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984;33:271–276
  3. Grauslund J, Green A, Sjolie AK. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia. 2008;51:583–588
  4. Green A, Hauge M, Holm NV, Rasch LL. Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia. 1981;20:468–470
  5. Jorde R, Sundsfjord J. Intra-individual variability and longitudinal changes in glycaemic control in patients with Type 1 diabetes mellitus. Diabetic Medicine. 2000;17:451–456
  6. Kilpatrick ES, Rigby AS, Atkin SL. HbA1c variability and the risk of microvascular complications in type 1 diabetes: data from the DCCT. Diabetes Care. 2008;31:2198–2202
  7. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Archives of Internal Medicine. 2004;164:1917–1924
  8. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care. 1996;19:744–750
  9. Klein R, Moss SE, Klein BE. Change in glycemia in a four-year interval in younger-onset insulin-dependent diabetes. Annals of Epidemiology. 1992;2:283–294
  10. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, et al. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care. 1996;19:689–697
  11. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study, I: All-cause mortality in patients with insulin-treated diabetes mellitus. Diabetic Medicine. 1999;16:459–465
  12. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabetic Medicine. 1999;16:466–471
  13. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003;46:760–765
  14. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. American Journal of Public Health. 1991;81:1158–1162
  15. Moss SE, Klein R, Klein BE, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Archives of Internal Medicine. 1994;154:2473–2479
  16. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine. 2005;353:2643–2653
  17. Shankar A, Klein R, Klein BE, Moss SE. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. American Journal of Epidemiology. 2007;166:393–402
  18. Sibal L, Law HN, Gebbie J, Dashora UK, Agarwal SC, Home P. Predicting the development of macrovascular disease in people with type 1 diabetes: A 9-year follow-up study. Annals of the New York Academy of Sciences. 2006;1084:191–207
  19. Sjolie AK. Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmologica. Supplement. 1985;172:1–77
  20. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: The EURODIAB Prospective Complications Study. Diabetes Care. 2004;27:530–537
  21. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia. 2006;49:660–666
  22. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: A cohort study using the general practice research database. Diabetes Care. 2006;29:798–804
  23. World Health Organization . International classification of disease. Manual of the international statistical classification of diseases, injuries, and causes of death. 9th Rev.. Washington (DC): World Health Organization; 1977;
  24. World Health Organization. . International classification of disease and related health problems. 10th rev (ICD 10).. Washington (DC): World Health Organization; 1992;

PII: S1056-8727(09)00050-6

doi: 10.1016/j.jdiacomp.2009.05.003

Journal of Diabetes and Its Complications
Volume 24, Issue 4 , Pages 223-228 , July 2010

Article Tools

* Image Usage & Resolution